Related Experiment Videos
Pseudomonas aeruginosa infections associated with use of contaminated medicaments
British Medical Journal
|August 7, 1976
Abstract:
Pseudomonas aeruginosa was recovered from three hospital-prepared medicaments being used on the wards. Sixty-six patients were studied to observe the effect of using these contaminated medicaments. Psaeruginosa was recovered from 29 patients; in five the strains recovered bore a close resemblance to strains previously isolated from the contaminated medicaments.
Insights
Hospital-prepared medicaments contaminated with Pseudomonas aeruginosa (P. aeruginosa) led to infections in 29 of 66 patients. Five patients showed P. aeruginosa strains similar to those found in the contaminated medicaments.
Area of Science:
- Medical Microbiology
- Hospital Infection Control
- Clinical Pharmacy
Background:
- Hospital-prepared medicaments can be a source of microbial contamination.
- Pseudomonas aeruginosa is an opportunistic pathogen frequently associated with healthcare-associated infections.
- The use of contaminated medical products poses a risk to patient safety.
Purpose of the Study:
- To investigate the presence of Pseudomonas aeruginosa in hospital-prepared medicaments.
- To assess the clinical impact of using these contaminated medicaments on patients.
- To determine if P. aeruginosa strains from patients originated from the medicaments.
Main Methods:
- Microbiological analysis of three hospital-prepared medicaments.
- Patient surveillance of 66 individuals using the medicaments.
- Comparison of Pseudomonas aeruginosa isolates from medicaments and patients using strain typing.
Main Results:
- Pseudomonas aeruginosa was detected in three hospital-prepared medicaments.
- P. aeruginosa was recovered from 29 out of 66 patients studied.
- Five patient-isolated strains closely matched the strains found in the contaminated medicaments.
Conclusions:
- Hospital-prepared medicaments can harbor Pseudomonas aeruginosa.
- Contaminated medicaments pose a significant risk for patient infection.
- Effective quality control measures are crucial for hospital-prepared pharmaceuticals to prevent healthcare-associated infections.